Company Review
Healthgen Biotechnology Corp. (Healthgen Biotech) is a private company founded in 2006. We are focusing on developing, manufacturing and marketing a series of environmental friendly and safe products by using the State-of-the-Art platform called Oryz HiExp, having high capacity to express proteins or small peptides in the rice grain.
Using the Oryz HiExp platform, Healthgen Biotech maximizes the innovative animal-free product development opportunities for clients and partners. Its cost-effective expression capability made it as a breakthrough expression platform. Healthgen Biotech has achievements in developing and commercializing products, such as recombinant human serum albumin (OsrHSA), recombinant epidermal growth factor (OsrEGF), recombinant basic fibroblast growth factor (OsrbFGF), recombinant insulin-like growth factor-1 (OsrIGF-1) recombinant alpha-1 antitrypsin (OsrAAT), recombinant human lactoferrin (OsrLF), recombinant human lysozyme (OsrLYZ), and recombinant human fibronectin (OsrFn), which can be used as the cell culture media supplements, cellular therapy ingredients, vaccine excipients, cosmetic additives, industrial biological reagents in bio-pharmaceuticals processing and life science researches. The Quality Control System has been certified by ISO 9001: 2008 and ensures standardized process as well as qualified products.
Meanwhile, Healthgen Biotech can provide customized protein or peptides expression services, establish and optimize the cost effective extraction and purification process. The process route and infrastructure of large-scaled protein purification has been established, and can implement the industrial expression and production requirements.
Awards
2012 & 2016 Hubei Provincial Science and technology invention Award
2013 National Science and Technology Invention Award
2013 China Patent Excellence Award
Patents
Method for expressing small peptides using cereal non-storage proteins as fusion carrier in endosperm and the use thereof
●China patent no: ZL 2006 1 0019285.9
●US patent no: US 7,723,571 B2
●Japan patent no: JP 4,680,237
●EU patent no: EP1865064
●Canada patent no: CA2,587,092

A method for extracting recombinant human serum albumin from transgenic rice grain
●China patent no: ZL 2010 1 0597544.2
●US patent no: US 9,225,138 B2
●Japan patent no: JP 5,908,496
●EU patent no: EP 2655397
●SA patent no: 2013/04359

A method for isolating and purifying recombinant human serum albumin from transgenic rice grain
●China patent no: ZL 2012 1 0041102.9
●US patent no: US 9,023,990 B2
● Japan patent no: JP 5,948,343
●EU patent no: EP 2655396
●SA patent no: 2013/04358
●Australia patent no: AU2011348962

Production of recombinant human serum albumin with rice endosperm cells as biological reactor
●China patent no: ZL 2005 1 0019084.4

A method for extracting recombinant human serum albumin from cereal endosperms
●China patent no: ZL 2010 1 0597544.2

A method for purifying recombinant human serum albumin from rice seeds
●China application no: 201010604495.8

A callus-specific promoter of rice and the use thereof
●China application no: 201110054109.XRecombinant Basic Fibroblast Growth Factor Expressed From Rice
website:http://www.ralbumin.com/